Immune reconstitution during maintenance therapy in children with acute lymphoblastic leukemia, relation to co-existing infection

Hematology

Volumn 13, Issue 4, 2008, Pages 203-209

  El Chennawi, Farha A ^a   Al Tonbary, Youssef A ^b   Mossad, Youssef M ^a   Ahmed, Mona A ^a  

^a MANSOURA UNIVERSITY   (Egypt)

^b MANSOURA UNIVERSITY CHILDREN S HOSPITAL   (Egypt)

Author keywords

Acute lymphoblastic leukemia; Children; Immune reconstitution; Maintenance therapy

Indexed keywords

CD19 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD56 ANTIGEN; CD8 ANTIGEN; CORTICOSTEROID; CREATININE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MERCAPTOPURINE; METHOTREXATE; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; B LYMPHOCYTE; BLOOD CELL COUNT; CELLULAR IMMUNITY; CHILD; CLINICAL ARTICLE; CLINICAL EXAMINATION; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE SEVERITY; FEMALE; FLOW CYTOMETRY; HELPER CELL; HUMAN; HUMORAL IMMUNITY; IMMUNE SYSTEM; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; INFECTION; LEUKOPENIA; LIVER FUNCTION TEST; LYMPHOCYTOPENIA; MAINTENANCE THERAPY; MALE; NATURAL KILLER CELL; PRIORITY JOURNAL; SUPPRESSOR CELL; T LYMPHOCYTE;

6-MERCAPTOPURINE; ADOLESCENT; ADRENAL CORTEX HORMONES; ANTIGENS, CD; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CASE-CONTROL STUDIES; CD4-CD8 RATIO; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; IMMUNOGLOBULINS; INFECTION; MALE; METHOTREXATE; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; TUMOR MARKERS, BIOLOGICAL; VINCRISTINE;

EID: 55849083523     PISSN: 10245332     EISSN: 16078454     Source Type: Journal    
DOI: 10.1179/102453308X316086     Document Type: Article

References (22)

1. Silverman LB, Weintein HL. Treatment of childhood leukaemia. Curr Opin Oncology 1997; 9(1): 26-33.
2. van Gool Sw, van Den Hove I, Ceuppens JI. Activation of the immune system in cancer patients. Med Pediatric Oncology 2000; 34(1): 1-9.
3. Caver TE, Slobod KS, Flynn PM, et al. Profound abnormality of the B/T lymphocyte ratio during chemotherapy for pediatric acute Lymphoblastic leukaemia. Leukaemia 1998; 12: 619-622.
4. Alanko S, Salmi TT, Pelliniemi TT. Recovery of natural killer cells after chemotherapy for childhood acute lymphoblastic leukaemia and solid tumors. Med Pediatr Oncol 1995; 24: 373-378.
5. Mackall CL, Fleisher TA, Brown MR, et al. Age, thymopoiesis, and CD4 + T-lymphocyte regeneration after intensive chemotherapy. N Eng J Med 1995; 332(3): 143-149.
6. Mustafa MM, Buchanan GR, Winick NJ, et al. Immune recovery in children with malignancy after cessation of chemotherapy. J Pediatric Hematology Oncology 1998; 20(5): 451-457.
7. Bostram BC, Sensel MR, Sather NH, et al. Dexamethasone versus prednisone and daily oral versus weekly intravenous mercaptopurine for patients with standard-risk acute lymphoblastic leukemia: A report from the Children's Cancer Group. Blood 2003; 101(10): 3809-3817.
8. Kostaridou S, Polychronopoulou S, Psarra K, et al. Decrease of CD4 and B-lymphocyte populations is not associated with severe infectious complications in children with acute lymphoblastic leukaemia during maintenance. Int J Hematol 2004; 80(4): 354-360.
9. Luczynski W, Stasiak A, Krawczuk-Rybak. Immunological monitoring of maintenance therapy for acute lymphoblastic leukaemia in children - preliminary report. Pediatric Blood Cancer 2004; 42(5): 416-420.
10. Ek T, Mellander L, Andersson B, Abrahamsson J. Immune reconstitution after childhood acute lymphoblastic leukaemia is most severly affected in the high risk group. Pediat Blood Cancer 2005; 44(4): 461-468.
11. Mazur B, Szczepanski T, Karpe J, Jakimezyk DS, Bubala H, Torbus M. Decreased numbers of CD4 T-lymphocytes in peripheral blood after treatment of childhood acute lymphoblastic leukaemia. Leukaemia Research 2006; 30(1): 33-36.
12. Alanko S, Pelliniemi TT, Salmi TT. Recovery of blood B lymphocytes and serum immunoglobulins after chemotherapy for childhood acute lymphoblastic leukemia. Cancer 1992; 69: 1481- 1486.
13. Mackall CL, Hakim FT, Gress RE. T cell regeneration all repertoires are not created equal. Immunol Today 1997; 18(5): 245-251
14. Lovat PE, Robinson JH, Windebank KP, Kernahan J, Watson JG. Serial study of T lymphocytes in childhood leukaemia during remission. Pediat Haematol Oncol 1993; 10(2): 129-139.
15. Haraldsson A, Vaan GAMD, Dijk WJV, et al. Light chains ratios and concentrations of immunoglobulins G, A, and M in childhood common acute lymphoblastic leukaemia. Peadiatr Haematol Oncol 1994; 11: 83-90.
16. Abrahamsson J, Marky I, Mellander L. Immunoglobulin levels and lymphocyte response to mitogenic stimulation in children with malignant disease during treatment and follow up. Acta Pediatric 1995; 84: 177-82.
17. Smith S, Schiffma G, Karayalcin G, Bonagura V. Immundiffeciency in long term survivors of acute lymphoblastic leukaemia treated with BFM therapy. J Pediatric 1995; 127(1): 68- 75.
18. Azuma E, Nagai M, Qi J. CD4 Tlymphocytopenia in long term survivors following intensive chemotherapy in childhood cancers. Med Pediatr Oncol 1998; 30(1): 40-45.
19. Nilsson A, de Milito A, Engstrom P, et al. Current chemotherapy protocols for childhood acute lymphoblastic leukaemia induce loss of humoral immunity to viral vaccination antigens. Pediatrics 2002; 109(6): E91.
20. Lex C, Korholz DF, Kohnuller B, et al. Infectious complications in children with acute lymphoblastic leukaemia and T cell lymphopoma; a rationable for tailored supportive care. Support Care Cancer 2001; 9(7): 514-512.
21. Pizzo PA, Rubin M, Freifeld A, et al. The child with cancer and infection. I, Empiric therapy for fever and neutropenia and preventive strategies. J Pediatric 1991; 119(6): 845-857.
22. Borzy MS, Ridgway D. Prolonged defects of interleukin 2 production, responsivness and receptor expression in patients with acute lymphoblastic leukaemia. Blood 1989; 73: 1608- 1614.